OpenAlex
PricingAboutJobs
Log inGet started
Work

Desirable cell death during anticancer chemotherapy

HTML

Year: 2010
Type: review
Source: Annals of the New York Academy of Sciences
DOI: 10.1111/j.1749-6632.2010.05763.x
Authors: Clara Locher, Rosa Conforti, Laetitia Aymeric, Yuting Ma, Takahiro Yamazaki, Sylvie Rusakiewicz, Antoine Tesnière, François Ghiringhelli, Lionel Apetoh, Yannis Morel, Jean‐Philippe Girard, Guido Kroemer, Laurence Zitvogel
Institutions: Université Paris-Sud, Inserm, Institut Gustave Roussy, Centre Georges François Leclerc, Innate Pharma (France), Centre National de la Recherche Scientifique, Université Toulouse III - Paul Sabatier, Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, Centre de Recherche des Cordeliers, Assistance Publique – Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, Université Paris Descartes
Language: English

Topic: Immunotherapy and Immune Responses
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: immunogenic cell death, cancer chemotherapy, tumor antigen-specific T cells, immunoadjuvant, apoptosis, tumor immunology
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1592864174
FWCI: 1.027
Cites: 57
Cited by: 87
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security